Related Experiment Video
Updated: Oct 6, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Hybrid Surgery for Severe Mitral Valve Calcification: Limitations and Caveats for an Open Transcatheter Approach
Erik Bagaev1,2, Ahmad Ali1, Shekhar Saha1
1German Centre for Cardiovascular Research (DZHK), Department of Cardiac Surgery, Ludwig Maximilian University of Munich, Partner Site Munich Heart Alliance, 80539 Munich, Germany.
Insights
This study presents a hybrid approach for high-risk patients with severe mitral stenosis and extensive mitral annular calcification (MAC). The novel technique shows promising results for reducing surgical risks and improving outcomes in complex cases.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Biomaterials in Medicine
Background:
- Severe mitral stenosis with extensive mitral annular calcification (MAC) presents significant surgical challenges.
- Traditional surgical approaches carry risks such as prolonged surgery, ventricular rupture, and systolic anterior motion.
- Existing treatments often have limitations for patients with severe MAC.
Purpose of the Study:
- To evaluate a novel hybrid approach for mitral valve replacement in patients with severe mitral stenosis and extensive MAC.
- To reduce the risks of ventricular rupture, paravalvular leaks, and outflow tract obstruction.
- To assess the feasibility and early outcomes of this alternative surgical strategy.
Main Methods:
- A hybrid approach involving open implantation of an Edwards Sapien 3 prosthesis was performed on cardiopulmonary bypass in six female patients (mean age 76 ± 9 years).
- The technique included resection of the anterior mitral leaflet, placement of anchor sutures, and visual deployment of a balloon-expandable prosthesis.
- Concomitant procedures were performed in three patients.
Main Results:
- Mean cross-clamp time was 95 ± 31 min and cardiopulmonary bypass time was 137 ± 60 min.
- Perioperative TEE revealed typical gradients and clinically irrelevant paravalvular leakage in the anterior annulus in three patients.
- Mild to moderate gradients were noted in the left ventricular outflow tract; no cerebrovascular events or pacemaker implantations occurred. Survival to discharge was 83.3% at one year.
Conclusions:
- The "off-label" implantation of the Edwards Sapien 3 prosthesis using this hybrid approach is a viable bail-out option.
- This method is suitable for high-risk patients or those deemed inoperable due to extensive MAC.
- The approach may mitigate risks associated with conventional mitral valve surgery in complex cases.
Abstract:
Background and Objectives: Mitral stenosis with extensive mitral annular calcification (MAC) remains surgically challenging in respect to clinical outcome. Prolonged surgery time with imminent ventricular rupture and systolic anterior motion can be considered as a complex of causal factors. The aim of our alternative hybrid approach was to reduce the risk of annual rupture and paravalvular leaks and to avoid obstruction of the outflow tract. A review of the current literature was also carried out. Materials and Methods: Six female patients (mean age 76 ± 9 years) with severe mitral valve stenosis and severely calcified annulus underwent an open implantation of an Edwards Sapien 3 prosthesis on cardiopulmonary bypass. Our hybrid approach involved resection of the anterior mitral leaflet, placement of anchor sutures and the deployment of a balloon expanded prosthesis under visual control. Concomitant procedures were carried out in three patients. Results: The mean duration of cross-clamping was 95 ± 31 min and cardiopulmonary bypass was 137 ± 60 min. The perioperative TEE showed in three patients an inconspicuous, heart valve-typical gradient on all implanted prostheses and a clinically irrelevant paravalvular leakage occurred in the anterior annulus. In the left ventricular outflow tract, mild to moderately elevated gradients were recorded. No adverse cerebrovascular events and pacemaker implantations were observed. All but one patient survived to discharge. Survival at one year was 83.3%. Conclusions: This "off label" implantation of the Edwards Sapien 3 prosthesis may be considered as a suitable bail-out approach for patients at high-risk for mitral valve surgery or deemed inoperable due to extensive MAC.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Regurgitation III: Medical Management
Mitral Stenosis I: Introduction
Mitral Valve Prolapse II: Assessment and Management

